DUBLIN, Nov. 12, 2019 /PRNewswire/ -- The "ATP Assay Market by Product (Consumables (Kit, Reagent, Microplate), Instrument (Luminometer, Spectrophotometer)), Application (Contamination Test, Disease Test), End User (Pharmaceutical & Biotechnology Company, F&B), Region - Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.
The Global ATP Assays Market is Projected to Reach USD 315 Million by 2024 from USD 191 Million in 2019, at a CAGR of 10.5%.
In 2018, North America accounted for the largest share of the ATP assays market. The large share of North America can be attributed to the rising incidence and prevalence of chronic and infectious diseases, rising demand for cell-based assays in research, increasing focus on cell-based therapeutics, favorable government support for research, and the presence of high-quality infrastructure for clinical & laboratory research in the region.
Rising demand for ATP assays in pharmaceutical and biotechnology companies
Growth in this market is majorly driven by the increasing demand for ATP assays in pharmaceutical and biotechnology companies, rising investments in pharmaceutical and biotechnology R&D, increasing prevalence of cancer and other chronic and infectious diseases, and shift from culture-based tests to rapid tests.
The consumables & accessories segment will register the highest growth in the market, by product
Based on product, the market is segmented into consumables & accessories and instruments. The consumables & accessories segment is expected to witness the highest CAGR in the ATP assays market during the forecast period. The large share of this segment can be attributed to the high usage of ATP assays for microbial contamination testing and the growing applications of ATP assays in different industries like food & beverage and agriculture. Their high usage and the need for repeat purchases equate to a larger market share and higher growth rate.
Contamination testing is the largest application segment of the ATP assays industry
Based on application, the market is segmented into contamination testing, disease testing, and drug discovery & development. In 2018, the contamination testing segment accounted for the largest share of the ATP assays market. This is attributed to the high frequency of contamination testing protocols carried out by pharmaceutical & biotechnology companies, the food & beverage industry, and hospitals & diagnostic laboratories, among other end users.
Key Topics Covered:
2 Research Methodology
3 Executive Summary
4 Premium Insights
5 Market Overview
5.2 Market Dynamics
18.104.22.168 Growing Demand for ATP Assays in Pharmaceutical & Biotechnology Companies
22.214.171.124 Rising Investments in Pharmaceutical & Biotechnology R&D
126.96.36.199 Increasing Prevalence of Cancer
188.8.131.52 Shift From Culture-Based Tests to Rapid Tests
184.108.40.206 Rising Incidence and Prevalence of Chronic & Infectious Diseases
220.127.116.11 High Cost of Instruments
18.104.22.168 Technology Enhancements in ATP Assay Probes
22.214.171.124 Growth Prospects in Emerging Markets
6 ATP Assays Market, By Product
6.2 Consumables & Accessories
6.2.1 Reagents & Kits
126.96.36.199 Wide Applications of Reagents & Kits Account for the Large Share of This Segment
188.8.131.52 As Miniaturization of Microplates Provides High Utility Over Gel-Based Well Systems, Their Adoption is High in the Analytical and Life Science Industry
6.2.3 Other Consumables & Accessories
184.108.40.206 Luminometers are Comparatively Low-Priced and Therefore Widely Adopted
220.127.116.11 Spectrophotometers are Costlier Than Luminometers And, Therefore, Less-Preferred By End Users in the Market
7 ATP Assays Market, By Application
7.2 Contamination Testing
7.2.1 Need to Meet Regulatory Mandates for Contamination and Quality Testing is a Key Driver of Market Growth
7.3 Disease Testing
7.3.1 Growing Disease Incidence and Rising Awareness are Expected to Support Market Growth During the Forecast Period
7.4 Drug Discovery & Development
7.4.1 Increasing R&D Pipeline for Pharmaceutical Drugs Will Drive Market Growth
8 ATP Assays Market, By End User
8.2 Pharmaceutical & Biotechnology Companies
8.2.1 Growth in Drug R&D Pipelines to Increase the Focus of Pharma & Biotech Companies on Quality Control Measures - Driving Growth in the Market
8.3 Food & Beverage Industry
8.3.1 Incidents of Food Contamination Have Led to the Introduction of New Legislations for Food Safety Testing, Thereby Driving the Growth of the Market
8.4 Hospitals & Diagnostic Laboratories
8.4.1 Growing Demand for Early Diagnosis of Diseases is a Major Factor Driving the Adoption of ATP Assays
8.5 Academic & Research Institutions
8.5.1 ATP Assays are Used for Research Activities Related to the Growth Rate & Viability of Microorganisms
9 ATP Assays Market, By Region
9.2 North America
18.104.22.168 US to Dominate the North American Market
22.214.171.124 Availability of a Broad Range of Government Funding Programs to Support Life Science Research to Drive Market Growth
126.96.36.199 Demand for ATP Assays Will be Driven By the Large-Scale Outsourcing of Clinical Diagnostic Testing By Hospitals to Commercial Service Providers
188.8.131.52 Strong Agro-Food Sector and a Major Focus on Biotechnology R&D to Drive Market Growth in France
184.108.40.206 UK has the Largest Pharmaceutical R&D Expenditure in Europe
220.127.116.11 High Cancer Burden to Increase the Demand for ATP Assays in Italy
18.104.22.168 Growth in the Personalized Medicine Sector and Clinical Diagnostics Market to Drive the Market in Spain
9.3.6 Rest of Europe
9.4 Asia Pacific
22.214.171.124 High Incidence of Cancer to Increase the Demand for ATP Assays in Japan
126.96.36.199 Increasing Pharmaceutical R&D Investments in the Country to Support Market Growth
188.8.131.52 Growing Adoption of ATP Assay Techniques in Research and Clinical Applications to Drive Market Growth in India
9.4.4 Rest of Asia Pacific
9.5 Latin America
9.6 Middle East & Africa
10 Competitive Landscape
10.2 Market Ranking for Key Players in the ATP Assays Market
10.3 Competitive Leadership Mapping
10.3.1 Visionary Leaders
10.3.3 Dynamic Differentiators
10.3.4 Emerging Companies
10.4 Competitive Situations and Trends
10.5 Competitive Assessment of R&D Expenditure
10.6 Product Portfolio Analysis
11 Company Profiles
11.1 Thermo Fisher Scientific, Inc.
11.2 Promega Corporation
11.3 Merck KGaA
11.4 PerkinElmer, Inc.
11.5 Agilent Technologies, Inc.
11.6 Abcam PLC.
11.7 Lonza Group
11.8 Neogen Corporation
11.9 3M Company
11.10 Danaher Corporation
11.11 PromoCell GmbH
11.12 Geno Technology, Inc.
11.13 Abnova Corporation
11.14 AAT Bioquest, Inc.
11.15 BioThema AB
11.16 BioVision, Inc.
11.17 Hygiena, LLC.
11.19 Creative Bioarray
11.20 Canvax Biotech S.L.
11.22 MBL International Corporation (A Subsidiary of Jsr Corporation)
11.23 Ruhof Corporation
For more information about this report visit https://www.researchandmarkets.com/r/ezs59p
Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets